Ebselen is a new skin depigmenting agent that inhibits melanin biosynthesis and melanosomal transfer

Behrooz Kasraee,Damjan S. Nikolic,Denis Salomon,Pierre Carraux,Lionel Fontao,Vincent Piguet,Gholamhossein R. Omrani,Olivier Sorg,Jean-Hilaire Saurat

DOI: https://doi.org/10.1111/j.1600-0625.2011.01394.x

2011-11-15

Experimental Dermatology

Abstract:We assessed the ability of ebselen, a glutathione peroxidase mimic, to reduce pigmentation in various models. In murine B16 melanocytes, 25 μm ebselen inhibited melanogenesis and induced a depolymerisation of actin filaments. In co-cultures of B16 melanocytes with BDVII keratinocytes, a pretreatment of melanocytes with ebselen resulted in a strong inhibition of melanosome transfer to keratinocytes, as shown under optical and electron microscopy. In reconstructed epidermis, topical 0.5% ebselen led to a twofold decrease of melanin without affecting the density of active melanocytes. A similar result was obtained with topical 0.5% ebselen in black guinea pig ears. Ebselen induced a decrease of epidermal melanin parallel to a localisation of melanin and melanosomes in the basal layer. Ebselen appears as a new depigmenting compound that inhibits melanin synthesis and melanosome transfer to keratinocytes.

dermatology